Dexcom (DXCM) Interest Expenses (2010 - 2023)

Dexcom (DXCM) has 14 years of Interest Expenses data on file, last reported at $5.9 million in Q2 2023.

• Interest Expenses for Q2 2023 came in at $5.9 million, up 25.53% year-over-year; the trailing twelve-month figure through Mar 2024 was $5.9 million (down 68.28% YoY), and the FY2022 annual result was $18.6 million, down 1.06% from the prior year.
• Interest Expenses climbed to $5.9 million in Q2 2023 per DXCM's latest filing, from $4.6 million in the prior quarter.
• Over five years, Interest Expenses peaked at $24.4 million in Q3 2020 and troughed at -$42.4 million in Q4 2020.
• A 5-year average of $7.0 million and a median of $4.8 million in 2021 frame the typical range for Interest Expenses.
• The sharpest annual moves came in 2019 and 2020: Interest Expenses surged 212.5% in 2019, then sank 377.12% in 2020.
• A 5-year view of Interest Expenses shows it stood at $15.3 million in 2019, then slumped by 377.12% to -$42.4 million in 2020, then soared by 111.08% to $4.7 million in 2021, then changed by 0.0% to $4.7 million in 2022, then advanced by 25.53% to $5.9 million in 2023.
• Business Quant data shows DXCM's Interest Expenses at $5.9 million in Q2 2023, $4.6 million in Q1 2023, and $4.7 million in Q4 2022.